Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia

Featuring perspectives from Drs Jennifer Brown and Deborah Stephens, including the following topics: Introduction: First-Line Treatment of Chronic Lymphocytic Leukemia (0:00) Combining Bruton Tyrosine Kinase (BTK) Inhibitors with Venetoclax; Venetoclax Consolidation (36:57) Noncovalent BTK Inhibitors; Pirtobrutinib (42:59) CAR T-Cell Therapy; Lisocabtagene Maraleucel (51:26) Richter’s Transformation (56:31) CME information and select publications